Cardinal Health, Inc. $CAH is Liberty One Investment Management LLC’s Largest Position

Liberty One Investment Management LLC trimmed its stake in Cardinal Health, Inc. (NYSE:CAH) by 18.4% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 215,125 shares of the company’s stock after selling 48,382 shares during the quarter. Cardinal Health comprises 3.7% of Liberty One Investment Management LLC’s portfolio, making the stock its largest position. Liberty One Investment Management LLC owned about 0.09% of Cardinal Health worth $36,141,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of CAH. Wellington Management Group LLP lifted its position in Cardinal Health by 1,666.7% during the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after buying an additional 2,249,241 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after buying an additional 1,193,983 shares in the last quarter. Zurich Insurance Group Ltd FI lifted its position in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after buying an additional 927,950 shares in the last quarter. Nuveen LLC acquired a new position in Cardinal Health during the first quarter valued at approximately $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new position in Cardinal Health during the first quarter valued at approximately $104,951,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Wells Fargo & Company reaffirmed an “overweight” rating and set a $185.00 price target (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wall Street Zen cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Morgan Stanley reissued an “overweight” rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Finally, Evercore ISI reduced their target price on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $166.00.

Insider Transactions at Cardinal Health

In related news, insider Jessica L. Mayer sold 38,078 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the sale, the insider directly owned 48,457 shares of the company’s stock, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider directly owned 14,976 shares in the company, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock valued at $40,489,525 over the last ninety days. 0.12% of the stock is currently owned by corporate insiders.

Cardinal Health Price Performance

CAH opened at $157.26 on Tuesday. The stock has a market capitalization of $37.36 billion, a PE ratio of 24.38, a P/E/G ratio of 1.32 and a beta of 0.71. The firm’s fifty day moving average price is $151.86 and its 200 day moving average price is $152.10. Cardinal Health, Inc. has a 12-month low of $106.98 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the prior year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st were issued a $0.5107 dividend. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s dividend payout ratio is currently 31.63%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.